Reconciling multiple connectivity-based systems biology methods for drug repurposing.

Area of Science:

• Computational biology
• Pharmacology
• Bioinformatics

Background:

• Numerous in silico methods for drug repurposing have emerged in the last two decades to accelerate early drug development.
• Data-driven approaches, particularly those comparing differential transcriptomic signatures, are widely used.
• Integration of systems biology databases and network biology algorithms is a growing trend.

Purpose of the Study:

• To reconcile and clarify the common structures and specific strategies of various integrative in silico drug repurposing methods.
• To address the inconsistent formulation of similar computational approaches.
• To provide a homogenized framework for understanding these methods.

Main Methods:

• Classification of integrative methods into two main categories.
• Elucidation of common underlying structures and specific strategic differences.
• Development of schematic workflow representations for each method category.
• Presentation of a homogenized formulation for the analyzed methods.

Main Results:

• Identification of two primary categories of integrative in silico drug repurposing methods.
• Detailed schematic representations of method workflows.
• A unified formulation simplifying the understanding of diverse computational strategies.
• Clarification of similarities and differences among various approaches.

Conclusions:

• The review provides a structured overview of integrative in silico drug repurposing methods.
• Understanding commonalities and differences facilitates more consistent application and development of new tools.
• This work aims to harmonize the field and improve the efficiency of drug discovery.